1Mcewan AJ.Use of rad ionuclides for the palliation of bone metastases.Sem in Radiat Oncol,2000,10:103-14.
同被引文献30
1L Jost,F Roila.Management of cancer pain:ESMO clinical prac-tice guidelines[J].Ann Oncol,2010,21(supplement5):257-260.
2S Deandrea,M Montanari,L Moja,et al.Prevalence of undertreat-ment in cancer pain.A review of published literature[J].Ann On-col,2008,19(12):1985-1991.
3Tsugunobu ANDOH,Kenji SUGIYAMA,Masahide FUJITA,et al.Pharmacological evaluation of morphine and non-opioid analgesicadjuvants in a mouse model of skin cancer pain[J].Biol PharmBull,2008,31(3):520-522.
4NI Cherny.How to deal with difficult pain problems[J].Ann On-col,2005,16(Supplement 2):ii79-ii87.
5Marie Fallon,Geoffrey Hanks,Nathan Cherny.Principles of controlof cancer pain[J].BMJ,2006,332(29):1022-1024.
6Cielito C,Reyes-Gibby,Badi El Osta,et al.The influence oftumor necrosis factor-A-308 G/A andIL-6-174 G/C onpain and analgesia response in lung cancer patients receiving sup-portive care[J].Cancer Epidemiol Biomarkers Prev,2008,17(6):3262-3267.
7RE Coleman.Risks and benefits of bisphosphonates[J].Br J Canc-er,2008,98(11):1736-1740.
8Pierrick G Fournier,Verena Stresing,Frank H Ebetino,et al.howdo bisphosphonates inhibit bone metastasis in vivo[J]?Neopla-sia,2010,12(7):571.
9Darren J,Hillegonds,Stephen Franklin,et al.The management of painful bone metastases with an emphasis on radionuclide therapy[J].J Nati Med Association,2007,997(7):85-794.
10Wilson Tay,Kok-Yuen Ho.The role of interventional therapiesin cancer pain management[J].Ann Acad Med Singapore,2009,38(11):989-997.
